Rosacea Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting rosacea clinical trials across 6 countries. Studies span Not Applicable, Phase 2. Top locations include Sacramento, California, United States, Brooklyn, New York, United States, Changsha, Hunan, China. Updated daily from ClinicalTrials.gov.


Rosacea Trials at a Glance

12 actively recruiting trials for rosacea are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Sacramento, Brooklyn, and Changsha. Lead sponsors running rosacea studies include Integrative Skin Science and Research, Icon Cancer Foundation, and Clinact.

Browse rosacea trials by phase

About Rosacea Clinical Trials

Looking for clinical trials for Rosacea? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rosacea trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rosacea clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

Skin healthRosaceaMenopause+5 more
King's College London30 enrolled1 locationNCT07341087
Recruiting
Not Applicable

Rosacea Radiofrequency Microneedling

Rosacea, PapulopustularRosacea, Erythematotelangiectatic
University of Miami20 enrolled1 locationNCT06801717
Recruiting
Not Applicable

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

Erythematotelangiectatic Rosacea
The Fourth Affiliated Hospital of Zhejiang University School of Medicine186 enrolled1 locationNCT07343635
Recruiting
Phase 2

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Rosacea
Wright State University48 enrolled1 locationNCT06312813
Recruiting
Not Applicable

Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety

Rosacea
Xiangya Hospital of Central South University104 enrolled1 locationNCT07296497
Recruiting
Not Applicable

Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin

Erythematous Telangiectatic Rosacea
Beijing Sino-German Union Cosmetic Institute Co., Ltd.72 enrolled1 locationNCT07106957
Recruiting

Determinants of Chronic Inflammatory Skin Disease Trajectories

lichen planusRosaceaAlopecia Areata+5 more
University Hospital Schleswig-Holstein1,000 enrolled1 locationNCT05928169
Recruiting
Phase 2

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

Papular-pustular RosaceaPapulopustular Rosacea (PPR)Papulopustular Rosacea
Narrows Institute for Biomedical Research20 enrolled1 locationNCT06952517
Recruiting
Not Applicable

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

MelasmaRosaceaAcne+1 more
Integrative Skin Science and Research150 enrolled1 locationNCT05942248
Recruiting
Not Applicable

Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea

RosaceaSystemic Inflammation
Integrative Skin Science and Research24 enrolled1 locationNCT06072066
Recruiting
Not Applicable

Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort

Pachychoroid DiseaseOcular Rosacea
Clinact400 enrolled1 locationNCT06466018
Recruiting
Phase 2

The ROSEND Trial - A Randomised trial for the treatment of recalcitrant symptomatic rosacea using definitive volumetric modulated arc radiotherapy or standard dermatological treatment

Recalcitrant Rosacea
Icon Cancer Foundation40 enrolled3 locationsACTRN12622001585718